Business

Arcturus Therapeutics: Downgrading To "Hold" As CF Program Shifts Population Focus

Published

on

Arcturus Therapeutics: Downgrading To "Hold" As CF Program Shifts Population Focus

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version